1-3 of 3
Blake Lee Neubauer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts

Jeremy R. Graff, Ann M. McNulty, Kimberly Ross Hanna, Bruce W. Konicek, Rebecca L. Lynch, Spring N. Bailey, Crystal Banks, Andrew Capen, Robin Goode, Jason E. Lewis, Lillian Sams, Karen L. Huss, Robert M. Campbell, Philip W. Iversen, Blake Lee Neubauer, Thomas J. Brown, Luna Musib, Sandaruwan Geeganage, Donald Thornton
Journal: Cancer Research
Cancer Res (2005) 65 (16): 7462–7469.
https://doi.org/10.1158/0008-5472.CAN-05-0071
Published: 15 August 2005
View article titled, The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts
Open the PDF for The Protein Kinase Cβ–Selective Inhibitor, Enzastaurin (LY317615.HCl), Suppresses Signaling through the AKT Pathway, Induces Apoptosis, and Suppresses Growth of Human Colon Cancer and Glioblastoma Xenografts in another window
Journal Articles

The Selective Estrogen Receptor Modulator Trioxifene (LY133314) Inhibits Metastasis and Extends Survival in the PAIII Rat Prostatic Carcinoma Model

Blake Lee Neubauer, Ann M. McNulty, Marcio Chedid, Keyue Chen, Robin L. Goode, Mac A. Johnson, C. David Jones, Venkatesh Krishnan, Rebecca Lynch, Harold E. Osborne, Jeremy R. Graff
Journal: Cancer Research
Cancer Res (2003) 63 (18): 6056–6062.
Published: 01 October 2003
View article titled, The Selective Estrogen Receptor Modulator Trioxifene (LY133314) Inhibits Metastasis and Extends Survival in the PAIII Rat Prostatic Carcinoma Model
Open the PDF for The Selective Estrogen Receptor Modulator Trioxifene (LY133314) Inhibits Metastasis and Extends Survival in the PAIII Rat Prostatic Carcinoma Model in another window
Journal Articles

Comparative Antitumor Effects of Hormonal Ablation, Estrogen Agonist, Estrogen Cytotoxic Derivative, and Antiestrogen in the PAIII Rat Prostatic Adenocarcinoma

Blake Lee Neubauer, Kevin L. Best, Robin L. Goode, Mark L. Heiman, Dennis M. Hoover, David W. Robertson, Michael F. Sarosdy, Carl J. Shaar, Lee R. Tanzer, Ronald L. Merriman
Journal: Cancer Research
Cancer Res (1992) 52 (17): 4663–4671.
Published: 01 September 1992
View article titled, Comparative Antitumor Effects of Hormonal Ablation, Estrogen Agonist, Estrogen Cytotoxic Derivative, and Antiestrogen in the PAIII Rat Prostatic Adenocarcinoma
Open the PDF for Comparative Antitumor Effects of Hormonal Ablation, Estrogen Agonist, Estrogen Cytotoxic Derivative, and Antiestrogen in the PAIII Rat Prostatic Adenocarcinoma in another window